258 related articles for article (PubMed ID: 24549735)
1. In vitro-in vivo extrapolation method to predict human renal clearance of drugs.
Kunze A; Huwyler J; Poller B; Gutmann H; Camenisch G
J Pharm Sci; 2014 Mar; 103(3):994-1001. PubMed ID: 24549735
[TBL] [Abstract][Full Text] [Related]
2. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
[TBL] [Abstract][Full Text] [Related]
3. Prediction of human pharmacokinetics - renal metabolic and excretion clearance.
Fagerholm U
J Pharm Pharmacol; 2007 Nov; 59(11):1463-71. PubMed ID: 17976256
[TBL] [Abstract][Full Text] [Related]
4. Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro-in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugs.
Poulin P
J Pharm Sci; 2013 Jul; 102(7):2085-95. PubMed ID: 23613473
[TBL] [Abstract][Full Text] [Related]
5. Novel minimal physiologically-based model for the prediction of passive tubular reabsorption and renal excretion clearance.
Scotcher D; Jones C; Rostami-Hodjegan A; Galetin A
Eur J Pharm Sci; 2016 Oct; 94():59-71. PubMed ID: 27033147
[TBL] [Abstract][Full Text] [Related]
6. Quantitative structure-pharmacokinetic relationships for the prediction of renal clearance in humans.
Dave RA; Morris ME
Drug Metab Dispos; 2015 Jan; 43(1):73-81. PubMed ID: 25352657
[TBL] [Abstract][Full Text] [Related]
7. Prediction of the overall renal tubular secretion and hepatic clearance of anionic drugs and a renal drug-drug interaction involving organic anion transporter 3 in humans by in vitro uptake experiments.
Watanabe T; Kusuhara H; Watanabe T; Debori Y; Maeda K; Kondo T; Nakayama H; Horita S; Ogilvie BW; Parkinson A; Hu Z; Sugiyama Y
Drug Metab Dispos; 2011 Jun; 39(6):1031-8. PubMed ID: 21383204
[TBL] [Abstract][Full Text] [Related]
8. The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.
Perri D; Ito S; Rowsell V; Shear NH
Can J Clin Pharmacol; 2003; 10(1):17-23. PubMed ID: 12687033
[TBL] [Abstract][Full Text] [Related]
9. Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data.
Poulin P; Haddad S
J Pharm Sci; 2013 Sep; 102(9):3239-51. PubMed ID: 23494893
[TBL] [Abstract][Full Text] [Related]
10. Physiological modelling of renal drug clearance.
Janků I
Eur J Clin Pharmacol; 1993; 44(6):513-9. PubMed ID: 8405004
[TBL] [Abstract][Full Text] [Related]
11. Characterization of LLC-PK1 kidney epithelial cells as an in vitro model for studying renal tubular reabsorption of protein drugs.
Takakura Y; Morita T; Fujikawa M; Hayashi M; Sezaki H; Hashida M; Borchardt RT
Pharm Res; 1995 Dec; 12(12):1968-72. PubMed ID: 8786975
[TBL] [Abstract][Full Text] [Related]
12. Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and In Vitro-In Vivo Extrapolation.
Scotcher D; Jones C; Posada M; Galetin A; Rostami-Hodjegan A
AAPS J; 2016 Sep; 18(5):1082-1094. PubMed ID: 27506526
[TBL] [Abstract][Full Text] [Related]
13. New IVIVE method for the prediction of total human clearance and relative elimination pathway contributions from in vitro hepatocyte and microsome data.
Riede J; Poller B; Umehara K; Huwyler J; Camenisch G
Eur J Pharm Sci; 2016 Apr; 86():96-102. PubMed ID: 26948853
[TBL] [Abstract][Full Text] [Related]
14. Renal drug transport: a review.
Bendayan R
Pharmacotherapy; 1996; 16(6):971-85. PubMed ID: 8947968
[TBL] [Abstract][Full Text] [Related]
15. Novel Mechanistic PBPK Model to Predict Renal Clearance in Varying Stages of CKD by Incorporating Tubular Adaptation and Dynamic Passive Reabsorption.
Huang W; Isoherranen N
CPT Pharmacometrics Syst Pharmacol; 2020 Oct; 9(10):571-583. PubMed ID: 32977369
[TBL] [Abstract][Full Text] [Related]
16. Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state.
Feng B; LaPerle JL; Chang G; Varma MV
Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):939-52. PubMed ID: 20433402
[TBL] [Abstract][Full Text] [Related]
17. Ontogeny of hepatic and renal systemic clearance pathways in infants: part II.
Alcorn J; McNamara PJ
Clin Pharmacokinet; 2002; 41(13):1077-94. PubMed ID: 12403644
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and clearances related to renal processes.
Garrett ER
Int J Clin Pharmacol Biopharm; 1978 Apr; 16(4):155-72. PubMed ID: 649235
[No Abstract] [Full Text] [Related]
19. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.
Vuppugalla R; Marathe P; He H; Jones RD; Yates JW; Jones HM; Gibson CR; Chien JY; Ring BJ; Adkison KK; Ku MS; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
J Pharm Sci; 2011 Oct; 100(10):4111-26. PubMed ID: 21480234
[TBL] [Abstract][Full Text] [Related]
20. Prediction of human renal clearance from preclinical species for a diverse set of drugs that exhibit both active secretion and net reabsorption.
Paine SW; Ménochet K; Denton R; McGinnity DF; Riley RJ
Drug Metab Dispos; 2011 Jun; 39(6):1008-13. PubMed ID: 21357702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
